Liu, Cong
Ji, Bangqun
Liang, Yao
Shi, Juan
Wang, Yufan
Ke, Tingyu
Li, Li
Zhao, Dong
Dai, Yuancheng
Dong, Qijuan
Xu, Fengmei
Peng, Ying
Wang, Weiqing
Zheng, Qidong
Zhang, Yifei
Funding for this research was provided by:
Capacity building for multidisciplinary cooperation in diagnosis and treatment of major metabolic diseases (No. Z155080000004)
Shanghai Hospital Development Center (SHDC22022301)
Noncommunicable Chronic Diseases-National Science and Technology Major Project (No.2023ZD0508100)
the National Natural Science Foundation of China (No. 82270896)
the Shanghai Medical and Health Development Foundation (No. DMRFP_II_01)
The Leader Project of the Oriental Talent Program in 2022 (No.153)
Article History
Received: 8 January 2025
Accepted: 9 May 2025
First Online: 24 May 2025
Declarations
:
: The study protocol was approved by the Ethics Committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine and by the ethics committees of all other participating centers. The study design followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.
: Not applicable.
: The authors declare no competing interests.